African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 13, No. 2, February 2026 | pp. 71–77

DOI: 10.46882/AJIDR/148921

Article Type: Research Article

Title: Genomic characterization and rifampicin resistance determinants of rpoB-mutated Mycobacterium leprae in multibacillary leprosy patients

Names of Authors: Chukwudi Nwankwo¹*, Freja Bergstrom², Vikram Kulkarni³

Authors’ Affiliations: ¹Department of Dermatology, University of Nigeria Teaching Hospital, Enugu, Nigeria. ²Department of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden. ³Department of Infectious Diseases, Christian Medical College, Vellore, India.

Abstract: Drug-resistant Mycobacterium leprae threatens global leprosy elimination efforts and complicates multidrug therapy outcomes in endemic communities. We investigated mutations in the drug resistance-determining regions of rpoB, folP1, and gyrA among newly diagnosed and relapsed multibacillary leprosy cases. Slit-skin smear biopsies from 140 patients were analyzed via multiplex polymerase chain reaction and targeted Sanger sequencing. Mutations conferring dapsone resistance (folP1) were detected in 7.1 percent of patients, while rifampicin resistance (rpoB) and ofloxacin resistance (gyrA) were identified in 2.9 percent and 2.1 percent, respectively. Routine molecular drug resistance surveillance is essential.

Keywords: Mycobacterium leprae, Multibacillary leprosy, Rifampicin resistance, Molecular surveillance, Neglected tropical diseases

Citation: Nwankwo C, Bergstrom F, Kulkarni V (2026). Genomic characterization and rifampicin resistance determinants of rpoB-mutated Mycobacterium leprae in multibacillary leprosy patients. African Journal of Infectious Diseases Research, 13(2): 71–77. DOI: 10.46882/AJIDR/148921

Manuscript Timeline: Received: December 12, 2025; Revised: January 14, 2026; Accepted: January 27, 2026; Published: February 02, 2026